Teyi Pharmaceutical Group (002728.SZ) has accumulated a repurchase of 2.48% of shares, costing 93.9418 million yuan.
Te Yi Pharmaceutical (002728.SZ) announced that as of February 28, 2025, the company will be traded through centralized bidding...
Teyi Pharmaceutical Group (002728.SZ) announced that as of February 28, 2025, the company repurchased 12.7296 million shares of its own stock through centralized bidding, representing 2.48% of the company's current total share capital. The total amount paid was RMB 93.9418 million (excluding related transaction costs).
Related Articles
The lifting of restrictions on restricted shares tests the fundamentals of STAR SPORTS MED (01609), and with sustained performance growth, the valuation has entered a reasonable range.
MNSO (09896) repurchased 107,400 shares for US$236,800 on October 2.
BUD APAC (01876): Internal restructuring generates US$52 million tax expense; additionally, a US$30 million provision is made for Indian receivables.
The lifting of restrictions on restricted shares tests the fundamentals of STAR SPORTS MED (01609), and with sustained performance growth, the valuation has entered a reasonable range.
MNSO (09896) repurchased 107,400 shares for US$236,800 on October 2.
BUD APAC (01876): Internal restructuring generates US$52 million tax expense; additionally, a US$30 million provision is made for Indian receivables.
